Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Nephrology · IgA Nephropathy and IgA-Dominant Infection-Related Glomerulonephritis

IgA Nephropathy vs. Infection-Related GN: What Differs?

At a Glance

The key difference is the cause: IgA nephropathy is an immune-mediated kidney disease, while IgA-dominant infection-related glomerulonephritis follows an active or recent bacterial infection. Doctors combine infection history, blood tests, and kidney biopsy findings because no single test is definitive.

While primary IgA nephropathy (IgAN) is an immune-mediated kidney disease driven by abnormal IgA antibodies depositing in the kidneys, IgA-dominant infection-related glomerulonephritis (IgA-IRGN) is a distinct condition that mimics it but is driven by an active or recent bacterial infection [1][2]. Distinguishing between the two is critical because adding strong immune-suppressing drugs to treat what is actually an active infection can be ineffective and potentially dangerous [3][4]. Doctors rely on a combination of clinical risk factors, blood tests, and specific kidney biopsy patterns to tell them apart, though both conditions share a foundation of kidney-protective care [5].

Clinical Clues and Risk Factors

IgA-IRGN typically develops as an immune reaction to a bacterial infection, most commonly a Staphylococcus (Staph) infection [1]. The infection might be obvious, like a skin infection or pneumonia, but it can also be occult (hidden from plain sight), such as a deep spinal abscess or a heart valve infection [6][7]. However, it is important to know that a recent infection can also trigger a flare of primary IgAN, so having had a recent infection does not automatically mean the disease is infection-related [8][9].

Compared to typical IgAN, people with IgA-IRGN are more likely to be older adults, have diabetes, and experience sudden acute kidney injury (a rapid, dangerous decline in kidney function) [1][10].

Blood tests also provide clues, though they are not definitive:

  • Low C3: C3 is a complement protein that acts as part of the immune system. It can get used up during certain infections, leading to lower levels in the blood [5][11].
  • Low serum albumin: Albumin is a protein in the blood that can drop due to urinary protein loss, severe illness, or inflammation [5].

These findings can support a diagnosis of IgA-IRGN, but they neither establish nor exclude it. C3 can be normal in infection-related disease, and low albumin is a nonspecific finding seen in many kidney conditions.

Interpreting the Kidney Biopsy

Under a microscope, both conditions show deposits of IgA antibodies in the kidneys, which is why they are easily confused [2]. However, pathologists (doctors who specialize in interpreting biopsies) look for specific microscopic patterns that favor an infection-related cause:

  • Endocapillary proliferation: A swelling and increase of cells inside the tiny blood vessels (capillaries) of the kidney filters, which is frequently seen in IgA-IRGN [5][10].
  • C3 Co-dominance: While IgA is present, the biopsy staining may show equally strong deposits of the C3 complement protein [1].
  • Subepithelial humps: When examined under a high-powered electron microscope, IgA-IRGN can produce distinct “hump-shaped” immune deposits on the outside of the capillary walls [12].
  • Crescents: Severe, active inflammation can cause cellular crescents (collections of proliferating cells and inflammatory material) in the kidney filters [12][1]. These represent active, severe injury rather than just scarring.

Because none of these biopsy features are 100% exclusive to infection—for example, subepithelial humps and crescents can occasionally be seen in primary IgAN—doctors cannot rely on the biopsy alone [13][2]. The pathology must always be interpreted alongside the patient’s symptoms, medical history, and clinical picture.

How Treatment Differences Impact Care

Both conditions require supportive, kidney-protective care. This usually involves blood pressure medications (like ACE inhibitors or ARBs) and sometimes other protective drugs like SGLT2 inhibitors [9].

The primary difference lies in how the underlying inflammation is managed:

  • For primary IgAN: If supportive care isn’t enough, doctors may selectively use immunosuppressants (like steroids) to quiet the overactive immune system [9].
  • For IgA-IRGN: The absolute priority is finding and controlling the underlying infection using targeted antibiotics and, if necessary, surgical drainage of abscesses [14][11].

Adding strong immunosuppressants for an active, underlying bacterial infection can precipitate severe sepsis and may be fatal [3][4]. Only in rare, carefully selected situations—and under expert specialist guidance—might a doctor consider cautious immunosuppression if the kidneys continue to aggressively decline after the infection is completely controlled [15]. Never start, stop, or change immunosuppressive medications without direct instructions from your care team.

When to Seek Urgent Care

Diagnostic uncertainty can be stressful, but it is necessary to ensure safe treatment. If you experience any of the following symptoms, you should seek urgent medical assessment, as they could indicate a severe infection or rapidly declining kidney function:

  • Fever, chills, or sudden confusion
  • A marked reduction in how much you urinate
  • Rapidly worsening swelling in your legs or face
  • Shortness of breath or severe unexplained illness

At-A-Glance Comparison

Feature Primary IgA Nephropathy (IgAN) Infection-Related (IgA-IRGN)
Typical Timing Can flare during or just after an infection Develops as a reaction to an active/recent bacterial infection
Common Risk Factors Can affect any age; often genetic/autoimmune Older age, diabetes, history of Staph infections
Blood Clues C3 complement levels are usually normal C3 complement levels are frequently low
Biopsy Clues IgA dominant; fewer active inflammatory cells Endocapillary proliferation, C3 co-dominance, humps
Treatment Focus Kidney-protective meds; selective immunosuppression Kidney-protective meds; antibiotics and infection control

Note: Overlap is common, and your care team will integrate all evidence to determine the best path forward.

Common questions in this guide

What is the main difference between IgA nephropathy and IgA-dominant infection-related glomerulonephritis?
IgA nephropathy is an immune-mediated kidney disease in which IgA deposits injure the kidney filters. IgA-dominant infection-related glomerulonephritis is an immune reaction to an active or recent bacterial infection. The two can overlap in appearance, so doctors use the full clinical picture rather than one finding.
Can a recent infection occur with either type of kidney disease?
Yes. An active or recent bacterial infection can trigger IgA-dominant infection-related glomerulonephritis, but an infection can also coincide with or trigger a flare of primary IgA nephropathy. Therefore, a recent infection alone does not establish which condition is present.
Which kidney biopsy findings suggest infection-related glomerulonephritis?
Endocapillary proliferation, equally strong C3 staining, subepithelial humps, and cellular crescents may support an infection-related cause. None is completely specific, so a pathologist and nephrologist interpret the biopsy with symptoms, infection history, and blood tests.
Does a low C3 level prove that my kidney disease is infection-related?
No. Low C3 can support infection-related disease, but C3 may remain normal, and low albumin can occur for many reasons. Blood results must be combined with infection evaluation and biopsy findings.
How are IgA nephropathy and infection-related glomerulonephritis treated differently?
Both conditions usually require kidney-protective care, such as blood pressure treatment. If primary IgA nephropathy remains active despite supportive care, a doctor may consider selective immunosuppression. If infection-related disease is suspected, the priority is treating the infection with targeted antibiotics and sometimes draining an abscess.
Why can immunosuppressive treatment be dangerous if an infection is present?
Strong immune-suppressing medicines can make an untreated bacterial infection worse and may lead to severe sepsis. When infection-related disease is suspected, doctors generally prioritize finding and controlling the infection before considering immunosuppression. Do not start, stop, or change these medicines without your care team’s instructions.
What symptoms require urgent medical attention?
Seek urgent medical assessment for fever, chills, sudden confusion, a marked drop in urine output, rapidly worsening swelling of the legs or face, shortness of breath, or severe unexplained illness. These symptoms can signal a serious infection or rapidly worsening kidney function.

Get notified when new evidence is published on Immunoglobulin A nephropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    Clinicopathological and prognostic study of IgA-dominant postinfectious glomerulonephritis.

    Huang Z, Chen B, Zhou Y, et al.

    BMC nephrology 2021; (22(1)):248 doi:10.1186/s12882-021-02462-3.

    PMID: 34225678
  2. 2

    Glomerulonephritides associated with infections.

    Havrda M

    Vnitrni lekarstvi 2022; (68(7)):432-437 doi:10.36290/vnl.2022.091.

    PMID: 36402567
  3. 3

    Staphylococcus-related glomerulonephritis and poststreptococcal glomerulonephritis: why defining "post" is important in understanding and treating infection-related glomerulonephritis.

    Glassock RJ, Alvarado A, Prosek J, et al.

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2015; (65(6)):826-32.

    PMID: 25890425
  4. 4

    Immunoglobulin A-Dominant Post-Infectious Glomerulonephritis Mimicking Henoch-Schönlein Purpura Nephritis in a Patient With Methicillin-Sensitive Staphylococcus aureus Bacteremia.

    Delk VD, Pasham V, McKinnon K, Shah P

    Cureus 2025; (17(6)):e86409 doi:10.7759/cureus.86409.

    PMID: 40688910
  5. 5

    A comparative study on the clinicopathological features and short-term prognosis of IgA-dominant infection-related glomerulonephritis and IgA nephropathy.

    Zhong J, Yangzong D, Wang Y, et al.

    BMC nephrology 2026; (27(1)).

    PMID: 42642725
  6. 6

    Staphylococcus-Associated Glomerulonephritis Mimicking Henoch-Schönlein Purpura and Cryoglobulinemic Vasculitis in a Patient With an Epidural Abscess: A Case Report and Brief Review of the Literature.

    Mahmood T, Puckrin R, Sugar L, Naimark D

    Canadian journal of kidney health and disease 2018; (5()):2054358118776325 doi:10.1177/2054358118776325.

    PMID: 29900000
  7. 7

    Infective Endocarditis-Associated Glomerulonephritis Caused by Streptococcus cristatus: A Case Report.

    Nakagawa Y, Yamamoto C, Morimoto M, et al.

    Kidney & blood pressure research 2026; (51(1)):658-668 doi:10.1159/000553296.

    PMID: 42378185
  8. 8

    KM55 Monoclonal Antibody Staining in IgA-Dominant Infection-Related Glomerulonephritis.

    Zhang M, Zhou W, Liu S, et al.

    Nephron 2021; (145(3)):225-237 doi:10.1159/000513269.

    PMID: 33596564
  9. 9

    IgA Nephropathy in Adults: A Review.

    Stoneman S, Teh JW, O'Shaughnessy MM

    JAMA 2026; (335(9)):799-813 doi:10.1001/jama.2025.25020.

    PMID: 41587026
  10. 10

    The features in IgA-dominant infection-related glomerulonephritis distinct from IgA nephropathy: a single-center study.

    Handa T, Kakita H, Tateishi Y, et al.

    Clinical and experimental nephrology 2018; (22(5)):1116-1127 doi:10.1007/s10157-018-1564-4.

    PMID: 29564665
  11. 11

    Clinicopathologic features of IgA-dominant infection-associated glomerulonephritis: a pooled analysis of 78 cases.

    Bu R, Li Q, Duan ZY, et al.

    American journal of nephrology 2015; (41(2)):98-106 doi:10.1159/000377684.

    PMID: 25765902
  12. 12

    Staphylococcus Infection-Associated GN - Spectrum of IgA Staining and Prevalence of ANCA in a Single-Center Cohort.

    Satoskar AA, Suleiman S, Ayoub I, et al.

    Clinical journal of the American Society of Nephrology : CJASN 2017; (12(1)):39-49 doi:10.2215/CJN.05070516.

    PMID: 27821389
  13. 13

    Significance of subepithelial deposits in patients diagnosed with IgA nephropathy.

    Kitamura M, Obata Y, Ota Y, et al.

    PloS one 2019; (14(2)):e0211812 doi:10.1371/journal.pone.0211812.

    PMID: 30785896
  14. 14

    IgA Dominant Infection Related Glomerulonephritis Mimicking Primary IgA Nephropathy in Methicillin-Sensitive Staphylococcus aureus Osteomyelitis.

    Klor B, Acharya PC, Cunningham I, et al.

    International journal of nephrology and renovascular disease 2026; (19()):578405 doi:10.2147/IJNRD.S578405.

    PMID: 42125487
  15. 15

    Successful hemodialysis withdrawal with glucocorticoid treatment after achieving infection control in a case of crescentic IgA-dominant staphylococcus-associated glomerulonephritis.

    Nishiyama Y, Matsumura M, Yasui Y, et al.

    CEN case reports 2026; (15(5)).

    PMID: 42752782

This comparison is for informational purposes only and does not constitute medical advice. Your nephrologist and care team should interpret your biopsy, blood tests, and infection history before treatment decisions.